Dataset from Phase 1, Open-label, Multiple-dose, and Age De-escalation Trial to Assess the Pharmacokinetics, Safety and Tolerability of Delamanid (OPC 67683) in Pediatric Multidrug-resistant Tuberculosis Patients on Therapy With an Optimized Background Regimen of Anti-tuberculosis Drugs
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00008980
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this trial is to determine the pediatric dose of delamanid that is equivalent
to the adult dose already shown to be effective against multidrug-resistant tuberculosis.
创建时间：
2024-11-26
